P380 A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis
Journal article

P380 A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis

  • Danese, S IBD Center Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
  • Hart, A St Mark's Hospital, Harrow, UK
  • Dignass, A Department of Medicine I, Agaplesion Markus Hospital, Goethe-University, Frankfurt am Main, Germany
  • Fiorino, G IBD Center Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
  • Louis, E CHU de Liège, Liège, Belgium
  • D'Haens, G Academic Medical Centre, Amsterdam, The Netherlands
  • Dotan, I The Sackler Faculty of Medicine Tel Aviv University, Tel Aviv, Israel
  • Rogler, G Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
  • Paridaens, K Global Medical Affairs Gastroenterology, Ferring Pharmaceuticals Center S.A, Saint-Prex, Switzerland
  • Peyrin-Biroulet, L Department of Gastroenterology and Inserm u954, Lorraine University, Nancy, France
Show more…
  • 2019-1-25
Published in:
  • Journal of Crohn's and Colitis. - Oxford University Press (OUP). - 2019, vol. 13, no. Supplement_1, p. S296-S297
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/67370
Statistics

Document views: 11 File downloads: